Company

Belay Diagnostics

Biotechnology Research 1375 W Fulton St 49 employees

Employees: 49
Contacts: 3
Emails: 3
Phones: 2

belaydiagnostics.com LinkedIn

Belay Diagnostics Overview

Headquarters: 1375 W Fulton St
Website: belaydiagnostics.com
Industry: Biotechnology Research
Employees: 49
Founded: 2022
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Cerebrospinal Fluid (CSF) Liquid Biopsy Molecular Diagnostic Testing Clinical Research Next-Generation Sequencing (NGS) Services Precision Medicine Support Clinical Decision Support Tools

About Belay Diagnostics

Belay Diagnostics is redefining how brain and spinal cord cancers are detected. Our advanced cerebrospinal fluid (CSF) testing platforms use next-generation sequencing (NGS) and quantitative polymerase chain reaction (qPCR) to identify genetic mutations, chromosomal abnormalities, and MGMT promoter methylation, providing clinicians and patients with a less invasive alternative to surgical biopsies. Our unique offerings help inform the diagnosis and management of primary CNS malignancies. We see our technological advances in CSF assays as offering clinicians alternative diagnostic tools for use in treatment decisions, while helping guide patients with a minimally invasive solution.

Belay Diagnostics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Belay Diagnostics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Kimberly Dulac, Shrm-Cp, Ryt	Leader - Educator - HR and Admin		View
Honey Reddi, Phd, Facmg	Laboratory Geneticist/teacher/mentor	Chicago, Illinois, United States	Email
Jeremy Wilson	Advancing Discoveries in Brain Cancer	Charlotte Metro, United States	Email Phone
Jerry Conway	Market Access Leadership - Life	Red Bank, New Jersey, United States	Email Phone